Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapagliflozin vs Dexamethasone in Pre-operative Management of Non-Diabetic Glioma
NCT06750458Phase 3Completed
- Sponsor
- Tanta University
- Start
- Jan 2025
- Primary completion
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dapagliflozin in glioma, sponsored by Tanta University. Started Jan 2025; status: completed.
02
Drugs
dapagliflozin
03
Conditions
glioma
Beyond the preview
Go deeper on NCT06750458.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06750458.